Concepedia

Author

J. Zwaveling

Leiden University Medical CenterORCID

Also Known As

J H Zwaveling, J ZWAVELING, J Zwaveling, J. H. Zwaveling, J. Zwaveling, J.H. Zwaveling, Juliette Zwaveling, Juliëtte Zwaveling, Zwaveling, J., Zwaveling, Juliëtte

76

Publications

1.6K

Citations

22

H-Index

67

Concepts

All Affiliations

Leiden University Medical CenterLeiden UniversityUniversity of AmsterdamAmsterdam UMC Location University of AmsterdamBambino Gesù Children's Hospital
JZ

About

J. Zwaveling is an author at Leiden University Medical Center specializing in medicine, pediatrics, and physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

15

750

2

Health Sciences

2

2

52

3

Allergy

2

2

363

4

Nursing

1

1

39

5

Public Health

1

1

14

J. Zwaveling

×

31

Publications

1.3K

Citations

20

H-Index

YearCitations

Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis

Imke H. Bartelink, Arief Lalmohamed, Elisabeth M L van Reij,

The Lancet Haematology

2016

279

Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation

Imke H. Bartelink, Robbert G. M. Bredius, Svetlana V. Belitser,

Biology of Blood and Marrow Transplantation

2009

122

Glutathione S-transferase Polymorphisms Are Not Associated With Population Pharmacokinetic Parameters of Busulfan in Pediatric Patients

J. Zwaveling, Rogier R. Press, Robbert G. M. Bredius,

Therapeutic Drug Monitoring

2008

84

Once-Daily Intravenous Busulfan with Therapeutic Drug Monitoring Compared to Conventional Oral Busulfan Improves Survival and Engraftment in Children Undergoing Allogeneic Stem Cell Transplantation

Imke H. Bartelink, Robbert G. M. Bredius, Tessa T. Ververs,

Biology of Blood and Marrow Transplantation

2007

83

Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity

J. Zwaveling, Robbert G. M. Bredius, S C L M Cremers,

Bone Marrow Transplantation

2004

73

Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data

Mehtap Derya Aydemirli, Ellen Kapiteijn, Kaylee R M Ferrier,

European Journal of Endocrinology

2019

53

An Electronic Health Record Text Mining Tool to Collect Real‐World Drug Treatment Outcomes: A Validation Study in Patients With Metastatic Renal Cell Carcinoma

Sylvia A. van Laar, Kim B. Gombert‐Handoko, Henk‐Jan Guchelaar,

Clinical Pharmacology & Therapeutics

2020

44

Liver and kidney function in patients with Covid‐19 treated with remdesivir

Sylvia A. van Laar, Mark de Boer, Kim B. Gombert‐Handoko,

British Journal of Clinical Pharmacology

2021

43

High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric <scp>HSCT</scp>: a prospective multicentre study

M. Y. Eileen C. van der Stoep, Alice Bertaina, Marloes H. ten Brink,

British Journal of Haematology

2017

41

Evaluation of rule effectiveness and positive predictive value of clinical rules in a Dutch clinical decision support system in daily hospital pharmacy practice

Mirjam K. Rommers, J. Zwaveling, Henk‐Jan Guchelaar,

Artificial Intelligence in Medicine

2013

39

Page 1